Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared a post on LinkedIn:
“Precise support to reduce the burden of drug costs?
The middle class with financial means, if it is urgent, serious and dangerous, will also be strengthened.”
